NCT04133740

Brief Summary

During surgery high concentrations of supplementary oxygen are routinely administrated. However, there is increasing evidence of potential harm with liberal oxygen therapy. The hypothesis of the present study is that oxygen therapy adjusted to a normal arterial oxygen target is feasible and will attenuate the side effects of supplementary oxygen therapy. The study design is a before-and-after study in which 25 patients will follow the standard regime with high concentrations of oxygen therapy and 25 patients will be treated with oxygen to achieve a normal value of arterial oxygenation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 21, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
Last Updated

October 28, 2019

Status Verified

October 1, 2019

Enrollment Period

10 months

First QC Date

October 18, 2019

Last Update Submit

October 24, 2019

Conditions

Keywords

A before-and-after studyOxygenation targeting

Outcome Measures

Primary Outcomes (1)

  • P/F ratio

    Ratio of fraction of inspired oxygen (FiO2) and partial pressure of arterial oxygen (PaO2)

    Third postoperative day

Study Arms (2)

Standard regime

ACTIVE COMPARATOR

Supplementary oxygen is given according to the standard regime with a fraction of inspired oxygen (FiO2) of at least 0.60 during mechanical ventilation and 3 liter/minute or more after weaning from the ventilator in the intensive care unit (ICU).

Drug: Oxygen

Oxygenation targeting

ACTIVE COMPARATOR

Supplementary oxygen is given to achieve a partial pressure of arterial oxygen (PaO2) within the normal range defined as 10-12 kPa (75-120 mmHg) during surgery and in the ICU.

Drug: Oxygen

Interventions

OxygenDRUG

Liberal versus conservative oxygen therapy.

Also known as: Oxygen therapy
Oxygenation targetingStandard regime

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for elective cardiac surgery either coronary artery bypass grafting and/or valve replacement performed with use of cardiopulmonary bypass

You may not qualify if:

  • Left ventricular ejection fraction below 30 percent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Intensive Care, Aalborg University Hospital

Aalborg, 9000, Denmark

Location

MeSH Terms

Conditions

HyperoxiaAcute Lung Injury

Interventions

Oxygen

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsLung InjuryLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Study Officials

  • Bodil S Rasmussen, MD

    Aalborg University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A before-and-after study in which the first half to the planned patients are following the standard regime for oxygen therapy with a fixed amount and the other half of the patients receive oxygen therapy to achieve normal levels of partial pressure of arterial oxygen.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, consultant

Study Record Dates

First Submitted

October 18, 2019

First Posted

October 21, 2019

Study Start

October 1, 2018

Primary Completion

July 15, 2019

Study Completion

July 31, 2020

Last Updated

October 28, 2019

Record last verified: 2019-10

Locations